Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
196 Cards in this Set
- Front
- Back
what is another name for fever?
|
pyrexia
|
|
define pyrexia
|
elevation in core body temp that occurs due to a changed thermoregulatory set point in the hypothalamus
|
|
define hyperthermia
|
elevation in core body temperature that occurs without a change in the hypothalamic set point
|
|
what are two major etiologies of hyperthermia
|
1. heat stroke
2. malignant hyperthermia |
|
what is heat stroke?
|
form of non-pyrogenic hyperthermia that occurs when heat-dissipating mechanisms of the body cannot accommodate excessive heat
|
|
what is malignant hyperthermia?
|
uncommon, familial non-pyrogenic hyperthermia that occurs secondary to some anesthetic agents (e.g. halothane) and muscle relaxants
|
|
balance between heat load and heat-dissipating mechanisms
|
thermal homeostasis
|
|
what are the two major components of thermal homeostasis?
|
1. heat load
2. heat dissipation |
|
what are two major sources of heat load?
|
1. environmental heat
2. heat generated by metabolism and exercise |
|
what are four ways the body can dissipate heat?
|
1. radiation
2. convection 3. conduction 4. evaporation |
|
what internal mechanism causes the hypothalamus to change its set point temperature?
|
thermoreceptors sense change in ambient or core body temperature
|
|
what are six ways in which an animal will thermoregulate to elicit heat loss due to a signal from the hypothalamus?
|
1. panting
2. vasodilation 3. postural change 4. seek cold environment 5. perspiration 6. grooming |
|
what are the two basic ways that the body will elicit heat gain in response to a signal from the hypothalamus?
|
1. increased production of heat
2. decreased loss of heat |
|
what are three physiological responses by which the body will produce heat in response to a signal from the hypothalamus?
|
1. catecholamines
2. thyroxine (↑metabolism) 3. shivering |
|
what are four ways the body can decrease loss of heat?
|
1. vasoconstriction (maintain core body temp)
2. piloerection 3. postural changes 4. seek warm environment |
|
what type of chemical stimulates fever?
|
prostaglandins
|
|
what is the pathophysiologic pathway by which fever is initiated?
|
exogenous pyrogens → endogenous pyrogens → bind to vascular epithelium in the hypothalamus → stimulate prostaglandin release → ↑thermoregulatory set point
|
|
what are six examples of exogenous pyrogens?
|
1. infectious agents
2. antigen-antibody complexes 3. bile acids 4. drugs 5. tissue inflammation 6. necrosis |
|
upon stimulation by exogenous pyrogens, what is the source and composition of the endogenous pyrogens released into the blood?
|
cytokines released from leukocytes (IL-1, IL-6, IFN-β, IFN-γ, TNF-α)
|
|
what type of exogenous pyrogen can directly activate the hypothalamus, thus bypassing the endogenous pyrogenic pathway?
|
microbial toxins
|
|
what is the second-messenger responsible for changing the setpoint in the hypothalamus?
|
cAMP
|
|
what are six undesirable potential consequences of fever?
|
1. increase metabolic demands
2. muscle catabolism 3. suppressed erythropoiesis 4. increased fluid and caloric needs 5. DIC 6. shock |
|
what are two ways in which fever is directly protective to the body?
|
1. inhibit viral replication
2. cytotoxic or cytostatic to microbial pathogens |
|
what are five indirect ways in which fever is protective to the body?
|
1. ↓iron uptake by microbes
2. ↑microbial death within phagocytes 3. ↑lymphocyte transformation and activation 4. ↑granulocytic mobility 5. improve monocytic oxidative metabolism |
|
what is FUO
|
fever of unknown origin
|
|
in veterinary medicine, what conditions are required to diagnose a FUO?
|
- fever of sufficient duration to rule out common, simple, or self-limiting causes
- initial tests do not reveal specific cause - failure to respond to short course of antibiotics |
|
what should a client be warned about when the patient is diagnosed with a FUO?
|
- time consuming and frustrating
- may need additional tests - may need to repeat tests - can become expensive - 10-15% cases are undiagnosed |
|
what are some potential rule-outs for FUO?
|
- disease from travel
- recent vaccination - heartworm, FeLV/FIV - medication - response to therapy - Hx of other illness, Sx - subtle signs of illness (pain, lameness) - illness in other pets or humans in household |
|
in a physical exam, what is
- the max temperature that may be due to stress? - the max temperature of a fever? |
- stress: up to 103 °F
- fever ≤ 106 °F |
|
what is the next step if all diagnostic tests performed still yield an FUO?
|
therapeutic trial
|
|
what are six undesirable outcomes of a therapeutic trial for an FUO?
|
1. exacerbate undiagnosed disease
2. continued progression of an undiagnosed disease 3. drug toxicity/side effects 4. induction fo antibiotic resistance 5. interfere with future diagnostics 6. expensive |
|
in a therapeutic trial for a FUO using corticosteroids:
- indications for glucocorticoids - contraindications - complications - how long will therapy take to resolve clinical signs? |
- indicated for immune-mediated disease
- contraindicated if infection cannot be ruled out - may mask clinical signs and may complicate Dx of neoplasia - if immune-mediated FUO, pyrexia and clinical signs usually resolve in 24-28 hours |
|
how is mild-to-moderate fever initially treated?
|
since fever may have beneficial effects, ensure adequate fluid therapy and nutritional support. If this does not work, consider antipyretics.
|
|
why should you not cool an animal with a fever?
|
because the thermoreceptors will tell the hypothalamus that the body temp is lower and the fever could be worsened by elevation of the hypothalamic set point
|
|
what are three side effects to consider when using antipyretics?
|
1. hypothermia
2. impairment of host immune defenses 3. other side effects such as GI, renal, hepatic, etc. |
|
when using NSAIDs as antipyretics, what (two) drug types should they not be combined with?
|
1. don't mix multiple NSAIDs
2. don't use with corticosteroids |
|
give five examples of commonly-used NSAID antipyretics
|
1. salicylates (aspirin)
2. carprofen 3. deracoxib 4. meloxicam 5. fibrocoxib |
|
what is the only NSAID that can be used in cats?
|
Meloxicam labeled SC, off-label for oral
|
|
if an animal is in heat stroke:
- what temperature can lead to tissue and organ damage over time? - what temperature will lead to death in a few minutes? |
- >107 °F causes tissue and organ damage
- >110 °F for a few minutes causes death |
|
what are two common effects on the CNS due to heat stroke?
|
1. thermal injury to cerebral vascular endothelium
2. parenchymal thrombosis and hemorrhage associated with DIC |
|
what are four consequences of CNS parenchymal thrombosis and hemorrhage (associated with DIC) during heat stroke?
|
1. neuronal injury and cell death
2. cerebral edema 3. cerebellar dysfunction 4. damage to thermoregulatory center (predisposition to subsequent hyperthermic episodes) |
|
what are two major GI/hepatic effects of heat stroke?
|
1. direct thermal injury to GI cells and hepatocytes
2. ischemic from prolonged splanchnic hypotension |
|
as a result of heat stroke, what are two common outcomes of splanchnic ischemia?
|
1. hepatocellular necrosis and cholestasis
2. GI ischemia and ulceration |
|
if GI ischemia and ulceration result from heat stroke, what are three ways in which GI flora can cause disease?
|
1. bacterial translocation
2. endotoxemia 3. sepsis |
|
what are two major renal effects of heat stroke?
|
1. acute renal failure fron tubular necrosis
2. pre-renal azotemia |
|
what are four pathophysiologic mechanisms by which heat stroke can cause acute renal failure due to tubular necrosis?
|
1. direct thermal injury to tubular epithelium
2. hypoxia due to hypovolemia 3. microthrombi associated with DIC 4. nephrotoxicity from myoglobin released via rhabdomyolysis |
|
why does heat stroke cause hypovolemia?
|
direct thermal damage to the heart causes necrosis of the myocardium, and a downward spiral of arrhythmia → ↓CO → hypoperfusion → ischemia → more necrosis
|
|
what are three CV clinical signs on diagnosis of hyperthermia?
|
-initially tacky, HYPEREMIC mucous membranes that may become ashen and pale with prolonged CRT
- initially, tachycardia with bounding pulses; may turn into thready pulses, arrhythmias - petechiations, ecchymosis |
|
what are four characteristics of a CBC in a patient with hyperthermia?
|
1. ↑hemoconcentration due to dehydration
2. hemolytic anemia with schistocytes and nRBC 3. leukocytosis/leukopenia due to inflammation and/or sepsis 4. thrombocytopenia due to consumption (DIC), ↑loss in GI tract, and thermal injury to megakaryocytes |
|
what are three non-pharmaceutical ways to correct hyperthermia?
|
1. clip thick hair coats
2. spray or immerse in cool water, then cool with fan 3. cool water lavage or enemas |
|
if treating an animal for hyperthermia, at what temperature do you discontinue treatment?
|
103 °F
|
|
what is POVMR?
|
Problem Oriented Veterinary Medical Record
|
|
in a POVMR, what is the definition of a Problem?
|
anything that might interfere with the animal's well being and MIGHT require further evaluation and treatment
|
|
when stating a Problem in a POVMR, in how much detail do you define that problem?
|
at the highest level of refinement, but not overstated
|
|
in a POVMR, in what two basic ways are problems recorded?
|
1. a temporary problem list
2. a master problem list |
|
what accompanies a temporary problem list?
|
initial plan
|
|
what are the four components of a temporary problem list/initial plan?
|
1. problem
2. rule outs 3. Dx plan 4. Rx plan |
|
in what order are problems listed on a master problem list?
|
from the most important problem to the least important problem?
|
|
how often is a temporary problem list/initial plan updated?
|
at least daily
|
|
what are the four major components of a master problem list?
|
1. table of contents
2. problems dated from origin 3. numerical order from origin 4. may contain vaccination, tests, and drugs dispensed information |
|
for a problem in the POVMR, what are the five fates of a problem?
|
1. refined with accumulation of tests
2. combined with another 3. temporarily inactivated 4. resolved 5. removed - in error, was never a problem |
|
in a POVMR, what would two problems be combined?
|
when further assessment determines these problems are caused by the same thing, a refinement of the problem list
|
|
what method is used to rule out diseases when refining the problem?
|
bifurcation
|
|
what is used to detail the progress of a problem?
|
a SOAP
|
|
what does SOAP stand for?
|
Subjective, Objective, Assessment, Plan
|
|
in making a SOAP
- how do you record multiple problems? - what are good practices to allow others to easily read the document? |
- each problem is recorded separately and referenced by number from the Master Problem List
- be concise, use phrases and abbreviation, write legibly |
|
what are three basic components of the Subjective portion of a SOAP?
|
1. historical
2. overall assessment 3. observations not easily quantified (e.g. "stronger, better appetite") |
|
what are two basic components of the Objective portion of a SOAP?
|
1. daily physical exam findings
2. Quantified data (e.g. lab results, radiographic findings, ECG, neuro exam) |
|
what are four common components of the Assessment portion of a SOAP?
|
1. interpretation and explanation of problem at this time period
2. current differential diagnosis 3. evaluation of treatment plan 4. how this case differs from a typical case |
|
what are the three components of a Daily Plan on a SOAP?
|
Diagnosis (Dx), Treatment (Rx), and Client Education (CE)
|
|
what is recorded on a SOAP Daily Dx Plan?
|
1. what tests will be performed in the next 24 hours
2. a box for initials and time check offs |
|
what is recorded on a SOAP Daily Rx Plan?
|
1. a list of therapeutic objectives and goals
2. what treatments will be administered in the next 24 hours (including dose, frequency, and route of administration) 3. a box for initials and time check offs |
|
what is recorded on a SOAP Daily CE?
|
1. list time of communication
2. person talked with 3. summarize conversation (update condition, discuss new Dx tests or Rx, update bill) |
|
what are the three basic components fo shock?
|
1. inadequate systemic oxygen and nutrient delivery
2. impaired utilization of oxygen 3. poor tissue perfusion |
|
when in shock, what three pathophysiological mechanisms result in poor tissue perfusion?
|
1. vasoconstriction
2. decreased cardiac output 3. vasodilation |
|
what are the three basic forms of shock?
|
1. hypovolemia
2. distributive 3. cardiogenic |
|
what are the two subtypes of hypovolemic shock?
|
1. hemorrhagic
2. relative |
|
what is distributive shock and what are two major etiologies?
|
- vasodilation, effectively removing blood from circulation
- sepsis or anaphylaxis |
|
basically, what causes cardiogenic shock?
|
decreased cardiac output
|
|
what comprises the compensatory response to hypotension with hypovolemic shock?
|
- sympathetic activation, RAAS, ADH: vasoconstriction, ↑cardiac contractility, fluid retention
-redistribution of blood flow toward heart, brain and lungs, and away from splanchnic and skin |
|
what are the three core areas of circulation during hypovolemia?
|
brain, heart, lungs
|
|
at what point does shock occur in hypovolemia?
|
when compensation is inadequate or excessive and results in impaired tissue perfusion
|
|
how can compensatory mechanisms contribute to the clinical signs of hypovolemic shock
|
among other reasons, vasoconstriction may impair the blood flow to some organs
|
|
what is the basic pathogenesis leading to hypovolemic shock?
|
primary disease → compensated shock → decompensated shock
|
|
what are some clinical signs of compensated hypovolemic shock?
|
- may be subtle
- tachycardia - bounding pulses - tacky and/or pale mucous membranes - prolonged CRT |
|
what are some clinical signs of early decompensated hypovolemic shock?
|
- tachycardia progressing to bradycardia
- bounding pulses progressing to weak pulses - pale mucous membranes - cold extremities - depression - oliguria |
|
what is the basic goal in the treatment of hypovolemic shock? What is the basic means for doing this?
|
restore adequate oxygen delivery by restoring blood volume (resuscitation)
|
|
when resuscitating from hypovolemic shock, what are three positive outcomes of restoring blood volume?
|
1. increase preload →
2. increased CO → 3. increased tissue perfusion |
|
what is the shock dose of IV crystalloid for the dog and the cat?
|
dog: 90 ml/kg
cat: 60 ml/kg |
|
when giving IV crystalloids to treat hypovolemia
- how often do you assess response? - despite the typical "shock dose" of crystalloid, how much should be given? |
- assess every 10-15 minutes
- titrate to effect |
|
what are three common clinical signs that represent a positive response to IV fluids administered for hypovolemia?
|
1. decreased HR
2. improves pulse character 3. improved mucous membrane color and CRT |
|
hypertonic saline
- concentration - mechanism of action - time to effect - duration of action - typical dose |
- 7% NaCl
- water from interstitial and intercellular space to intravascular space - maximum effect in 5-10 minutes - short-lived effect - smaller volume than isotonic (4-5 ml/kg) |
|
when are colloids indicated in shock?
|
- hypoproteinemia (to avoid ascites/pleural effusion)
- lack of response to initial crystalloid administration |
|
when are vasopressors and/or positive inotropes indicated in hypovolemia?
|
- poor response to volume replacement
- severe hypotension or oliguria |
|
administration of vasopressors to treat hypovolemia:
- what type of drug is used? - what is the desired effect? - what are two examples of drugs to use? |
- α-adrenergic drugs
- increases effective circulating volume - norepinephrine, high dose dopamine |
|
administration of positive inotropes to treat hypovolemia:
- what type of drug is used? - what is the desired effect? - what is an example of a commonly used drug? |
- β1 agonist
- increased contractility → increased CO - dobutamine (also has weak β2 effect) |
|
rank the major effect (dominant neurotransmitter action) of dopamine administration depending on dose from low dose to high dose
|
- low: dopaminergic
- β-adrenergic - high: α-adrenergic |
|
when is oxygen delivery indicated in shock?
|
always
|
|
how can hypothermia be detrimental to treatment of shock and what are two ways to warm the patient?
|
it impairs vascular response to fluids
1. passive warming (e.g. Bair Hugger) 2. warm IV fluids |
|
for patients in shock, when is blood transfusion indicated? What is the goal?
|
- indicated when PCV < 20-25%
- goal is to maintain a PCV above 25%` |
|
what are four "other" supportive treatments used for shock?
|
1. bicarb to treat acidosis if present after volume replacement
2. GI protectants (H2 blockers such as cimetidine, ranitidine, famotidine) to treat/prevent GI ulceration 3. antibiotics for septic shock, GI hemorrhage, and translocation due to decompensatory shock 4. analgesia - opioids preferred |
|
list some things that should be monitored during treatment of shock
|
- TPR
- BW (watch for fluid overload) - MM color, CRT - urine output - lung sounds - electrolytes, PCV, TP - BP (keep > 60) |
|
what is the definition of sepsis?
|
systemic inflammatory response to infection
|
|
what is the definition of bacteremia?
|
presence of bacteria in the blood
|
|
what term is associated with a generalized, excessive inflammatory response to various stimuli?
|
systemic inflammatory response syndrome (SIRS)
|
|
what are four common risk factors for sepsis?
|
1. localized infection
2. immunosuppression 3. invasive devices (e.g. catheters) 4. surgery |
|
in sepsis, what is the initial cause for the pathogenesis of clinical signs
|
dying cells and bacterial antigens stimulate the host inflammatory response
|
|
in sepsis, what is the pathogenesis resulting from activation of the host inflammatory response?
|
1. ↑capillary permeability
2. vasodilation 3. activation of coagulation cascade → thrombosis 4. decreased cardiac function 5. multiple organ failure |
|
what are five clinical signs of early sepsis
|
1. depression
2. fever 3. tachycardia 4. red mucous membranes 5. rapid CRT |
|
what are two clinical signs that differ between early hypovolemia and sepsis?
|
1. hypovolemia: pale MM; sepsis: red MM
2. hypovolemia: prolonged CRT; sepsis: rapid CRT |
|
describe the cardiovascular effects of early septic shock
|
- peripheral vasodilation predominates:
- skin, GI tract - brick-red mucous membranes, strong pulses - vasoconstriction to kidney, heart - ↑HR, ↑contractility |
|
what are seven clinical signs of septic shock that has progressed beyond early stages?
|
1. fever or hypothermia
2. tachycardia 3. tachypnea 4. depression 5. weak pulses 6. slow CRT, pale MM 7. organ failure |
|
with chronic bacteremia, describe the severity of clinical signs. What are four clinical signs of chronic bacteremia?
|
- clinical signs are often mild
1. fever (intermittent) 2. lameness (polyarthritis) 3. vomiting 4. depression |
|
what are three important laboratory tests to perform in sepsis, and what information do they provide?
|
1. CBC - consistent with inflammation +/- hemoconcentration
2. urinalysis - bacteruria can occur in sepsis without clinical signs of UTI; culture the urine in suspected sepsis 3. blood chemistry - hypoalbuminemia (liver involvement); elevated liver enzymes; hyperbilirubinemia; hypoglycemia |
|
in searching for the origin of infection that may be causing sepsis, where are seven places to look?
|
1. gingiva
2. urinary tract 3. respiratory tract 4. abdomen 5. reproductive tract 6. cardiac valves 7. GI tract |
|
in diagnosing sepsis, what are three places that are important to culture?
|
1. primary site
2. urine 3. blood |
|
how do you determine the initial antibiotic to use when treating sepsis?
|
determine from the likely organisms at the primary site of infection, or from a Gram stain/cytology.
|
|
in antibiotic treatment of sepsis:
- route of administration - dosage - spectrum |
- administer IV
- use a high dose - use a broad spectrum initially and refine as Dx is refined |
|
what are five aspects of treating sepsis?
|
1. antibiotics
2. IV fluids 3. treatment for shock if present (vasodilation predominates) 4. treat complications (DIC, organ failure, hypoglycemia) 5. nutritional support |
|
what percentage of the body weight is water? What percentage of body weight is blood volume?
|
- 60% of body weight is water
- 7% of body weight is blood volume |
|
what are seven indications for fluid therapy?
|
1. rehydration
2. maintenance of hydration 3. expansion of intravascular volume 4. maintain or increase plasma oncotic pressure 5. correct electrolyte imbalances 6. diuresis 7. treat specific diseases |
|
what are five common etiologies for fluid loss?
|
1. PU/PD
2. vomiting/diarrhea 3. hemorrhage 4. fluid sequestration (e.g. pleural effusion or ascites) 5. lack of intake |
|
at what percentage dehydration is potentially lethal?
|
10%
|
|
what are six ways to assess hydration status?
|
1. skin turgor
2. mucous membranes 3. pulse rate and character 4. CRT 5. urinary bladder 6. body weight |
|
under what percentage dehydration is "undetectable"?
|
< 5%
|
|
what are clinical signs for 5-6% dehydration?
|
subtle loss of skin elasticity
|
|
what are clinical signs for 6-8% dehydration?
|
delayed skin tent, dry MM
|
|
what are clinical signs for 10-12% dehydration?
|
long skin tent, dry MM, slow CRT, sunken eyes, tachycardia, weak pulses
|
|
what are clinical signs for 12-15% dehydration?
|
hypovolemic shock
|
|
an animal presenting with subtle loss of skin elasticity is what % dehydrated?
|
5-6%
|
|
an animal presenting with delayed skin tent, dry MM is what % dehydrated?
|
6-8%
|
|
an animal presenting with long skin tent, dry MM, slow CRT, sunken eyes, tachycardia, and weak pulses is what % dehydrated?
|
10-12%
|
|
an animal presenting with hypovolemic shock is what % dehydrated?
|
12-15%
|
|
what are five routes of fluid administration?
|
1. oral
2. SC 3. intraperitoneal 4. IV 5. intraosseous |
|
what are four advantages of oral fluid therapy?
|
1. most physiologic route
2. no risk of overhydration 3. reduce electrolyte loss in diarrhea 4. inexpensive |
|
what are two disadvantages of oral fluid therapy?
|
1. not for vomiting, GI obstruction, NPO
2. slow absorption |
|
why do oral electrolyte solutions contain glucose
|
because they are co-transported
|
|
what are three advantages of SC fluids?
|
1. simple and economical
2. minimal risk of overhydration 3. OK for mild dehydration |
|
what are three disadvantages of SC fluids?
|
1. cannot correct moderate/severe dehydration
2. vasoconstriction impairs absorption 3. cellulitis possible |
|
SC fluids:
- concentration? - how much K+ maximum? - how much glucose? |
- isotonic
- K+ content up to 35 mEq/L - no glucose |
|
why is glucose not used in SC fluids?
|
- potential for infection
- glucose absorbed quickly, so solution will become hypotonic |
|
what are three advantages of IV fluids?
|
1. rapid administration possible
2. shock, diuresis, drug administration 3. hypertonic fluids OK |
|
what are four disadvantages of IV fluids?
|
1. IV catheter required
2. monitoring 3. risk of overhydration 4. expense |
|
where is an IV catheter placed for isotonic solutions?
|
peripheral vein: cephalic or saphenous
|
|
where is an IV catheter placed for hypertonic solutions?
|
jugular vein
|
|
how often must an IV catheter be changed?
|
every 72 hours
|
|
what are three advantages of intraosseus fluids?
|
1. use when other routes are inaccessible
2. rapid placement 3. rapid fluid absorption |
|
what are three disadvantages of intraosseous fluids?
|
1. infection, growth plate damage
2. risk of overhydration 3. may require pump |
|
what is the difference between a replacement crystalloid solution and a maintenance solution?
|
replacement may be given rapidly without detremental effects; maintenance is given to maintain fluid balance after replacement fluids have restored balance
|
|
maintenance solutions:
- electrolyte concentrations - comment on Na and Cl concentrations - comment on K+ - other additives - these are used in patients with what status of hydration? |
- electrolyte concentrations are similar to those lost in normal animal (urine, GI secretions)
- less Na and Cl than replacement (~ 40 mEq/L vs. 130-150 in replacement) - more K+ than replacement solutions - dextrose added to maintain isotonicity - use in adequately hydrated patient |
|
at what rate is hypertonic saline administered?
|
over 5-10 minutes (4-8 ml/kg)
|
|
give five examples of colloid solutions
|
1. dextrans
2. hetastarch 3. pentastarch 4. albumin 5. plasma |
|
what is the advantage of using colloids over hypertonic crystalloids?
|
they expand the intravascular volume for a longer period of time vs. hypertonic solutions
|
|
what are four indications for using colloids?
|
– Hypovolemia combined with:
• Hypoalbuminemia • Fluid accumulations (ascites, pleural effusion, edema) • Increased capillary permeability – Inadequate response to crystalloid – Shock – Hypotension during anesthesia |
|
what are three general aspects of a fluid therapy plan?
|
1. fluid volume
2. rate of administration 3. type of fluid |
|
how do you calculate fluid defecit?
|
1. estimate dehydration %
2. defecit volume = % dehydration x BW (kg) |
|
what is the maintenance fluid volume requirement in the average patient?
|
50 ml/kg/day
|
|
what are the two types of losses of fluid volume in a normal patient, where these originate, and amount of each?
|
1. insensible losses - fecal, respiratory, cutenaous - about 20 ml/kg/day
2. sensible losses - urinary - about 30 ml/kg/day |
|
what are three components used to calculate fluid volume in a fluid replacement plan?
|
1. fluid deficit
2. maintenance requirement 3. ongoing losses (e.g. vomiting, excess urination, diarrhea) |
|
how is a total fluid maintenance requirement calculated? How does animal morphology and age affect this value? What is the average range of maintenance requirement for dogs and cats?
|
- parallels basal energy requirements (1 mL/kcal)
- small and young animals have a higher fluid requirement per kg BW - average is 40-60 ml/kg/day in dogs and cats |
|
what are five ways in which pathologic ongoing losses of fluids can occur?
|
1. diarrhea
2. vomiting 3. polyuria 4. 3rd space loss (e.g. ascites) 5. bleeding |
|
what three questions should be answered when determining rate of fluid administration?
|
1. what was the rate of fluid loss?
2. what is the magnitude of loss? 3. what is the current circulatory status? |
|
over what time period should fluids be restored in:
- chronic loss? - acute loss? - shock? |
- chronic loss: 24-48 hr (usually 24 hr)
- acute loss: 2-6 hr - shock: 15-60 min (dog, 90 ml/kg/hr; cat, 60 ml/kg/hr) |
|
why are fluids replaced more slowly in chronic loss?
|
because rapid administration results in diuresis, not rehydration
|
|
which type of fluid should be used when:
- patient has diarrhea and vomiting from the duodenum (as well as stomach)? - patient is only vomiting gastric contents? |
- diarrhea + SI vomitus: standard replacement electrolyte solution
- gastric contents only: normal saline is ideal (due to metabolic alkalosis with hyponatremia and hypochloremia) |
|
what are three etiologies in which fluid retention will complicate fluid replacement? In these cases, what type of fluid should be used?
|
1. heart/hepatic failure
2. hypoalbuminemia 3. effuision/edema - use low sodium fluid or colloid except heart failure |
|
when monitoring fluid therapy, how often should you give a complete physical examination?
|
2x per day
|
|
what are six clinical signs of overhydration?
|
1. serous nasal discharge
2. chemosis (edema of the conjunctival tissue) 3. cough, dyspnea, crackles, ↑respiratiory rate 4. edema, ascites 5. shivering, restlessness 6. diarrhea, vomiting |
|
what are four causes of overhydration?
|
1. excessive fluid adminstration
2. oliguria 3. hypoproteinemia 4. imparied cardiac output |
|
if a dehydrated patient also presents for CRF, how does that change your fluid replacement plan?
|
- give fluids faster (fluid defecit + 6hr of maintenance over 6 hr)
- put on 2x maintenance - diurese |
|
what are four parameters to monitor in a patient on fluid therapy?
|
1. PCV, total solids
2. BW 3. urine output (1 ml/lb/hr) 4. central venous pressure if - fluid administration ≥ 90 ml/kg/hr for > 1 hr - low urine output - questionable cardiac function |
|
how does weight gain/loss correlate with fluid excess/deficit?
|
A gain or loss of 0.5 kg should be considered an excess or deficit of 500 ml of fluids
|
|
what is considered a normal urine output?
|
1-2 ml/kg/hr
|
|
what are five possible reasons for inadequate hydration despite fulid therapy?
|
1. calculation error
2. underestimation of fluid deficit 3. ongoing losses 4. rate of infusion to ohigh (diuresis rather than rehydration) 5. technical problems with the catheter |
|
why should oxygen supplementation be avioded in hyperthermia?
|
may contribute to overheating
|
|
what are two ways to treat DIC in hyperthemic patients?
|
1. transfusion
2. heparin |
|
in the hyperthemic patient, what are four ancillary treatments to prevent further complications?
|
1. treat DIC aggressively
2. prevent bacterial translocation & sepsis from GI (a/b and GI protectants) 3. correct hypoglycemia 4. correct acid/base and electrolyte abnormalities |
|
what type of drugs are contraindicated in hyperthermic patients and why?
|
NSAIDs, because they alter the hypothalamic set point
|
|
when treating for hyperthermia, what two drugs may be used to treat hypotension after resuscitation?
|
1. dopamine
2. dobutamine (β1 agonist) |
|
what is the average prognosis for severe hyperthemia? What determines the prognosis?
|
- guarded
- depends on length of time animal was hyperthermic, amount of organ damage, and response to intensive supportive care |
|
what are some poor prognostic indicators for hyperthemia?
|
- delayed admission (> 90 minutes)
- coma or neuro degen - hyopthermia on presentation - persistent hyperglycemia - ARF - DIC - refractory hypotension - hyperbilirubinemia - ventricular arrhythmias - persistent hypoproteinemia - dyspnea, pulmonary edema |
|
what drugs are used to treat primary immune mediated polyarthritis?
|
immunosuppressive doses of corticosteroids
|
|
what is anaphylaxis?
|
a severe local or systemic Type I hypersensitivity reaction
|
|
what type of antibodies mediate anaphylaxis?
|
IgE
|
|
how does IgE stimulate an anaphylactic reaction?
|
antigen cross-links IgE on mast cells, causing degranulation
|
|
what is the pathogenesis of a skin sensitization that leads to anaphylaxis?
|
antigen binds to dendritic cells → dendritic cells presents antigen to Th-cells in LN → B cell clonal expansion and enter the blood stream → B cells secrete IgE, which binds to mast cells → 2nd antigen exposure causes degranulation of mast cells by cross-linking of IgE
|
|
what are four major physiological effects of histamine release?
|
1. No production (vasodilation)
2. enhances leukocyte chemotaxis 3. stimunates arachadonic acid metabolites (e.g. prostaglandins/leukotrienes) 4. potentiates further mast cell degranulation |
|
what are the effects when histamine stimulates:
- smooth muscle? - exocrine secretions? - vasculature? |
- smooth muscle contraction (bronchi & SI); pulmonary vasoconstriciton
- bronchial mucus, rhinorrhea, lacrimation, salivation, gastric acid, pepsin - Wheal formation (swollen lump on the skin), edema, pruritis |
|
what are the major organs of anaphylaxis in:
- ruminants? - horses? - swine - cats? - dogs? |
- ruminants: respiratory tract
- horses: respiratory tract and intestine - swine: respiratory tract and intestine - cats: lung and respiratory tract - dogs: liver and GO tract |
|
what are five common causes of anaphylaxis?
|
1. vaccines
2. blood products 3. venom 4. food 5. drugs (e.g. a/b, opiates, NSAIDs) |
|
what are the ABC's of energency life support?
|
A- airways
B- breathing C- cardiovascular support |
|
what is the pharmaceutical first line of treatment for anaphylaxis? What routes of administration?
|
ephinephrine
- IV or intratracheal (diluted and 2x IV dose) - IM, SC in less severe presentations - CRI |
|
what are four drug types used when treating systemic anaphylaxis?
|
1. epinephrine
2. IV fluids (shock dose or to effect) - crystalloids, or colloids if needed 3. immunosuppressive levels of fast-acting corticosteroids 4. antihistamines IM; IV DOSES CAN CAUSE HYPOTENSION (not very useful during acute phase) |
|
when treating systemic anaphylaxis, what drugs are used to treat:
- refractory hypotension? - persistent bradycardia? - respiratory distress? |
- refractory hypotension: dopamine CRI
- persistent bradycardia: atropine - respiratory distress: inhaled bronchodilators (e.g. albuterol); oxygen; early elective intubation |
|
why should patients with localized anaphylaxis be monitored carefully?
|
because it can be systemic
|
|
what are two drugs used to treat localized anaphylaxis?
|
1. antihistamines (e.g. diphenhydramine)
2. corticosteroids (e.g. dexamethasone) |